Robyn J Barst Selected Research

Hypertension (High Blood Pressure)

10/2008	Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survival.
01/2008	Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension.
01/2008	Plasma serotonin levels are normal in pulmonary arterial hypertension.
12/2007	Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.
11/2007	Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease.
01/2007	Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentan.
01/2007	A review of pulmonary arterial hypertension: role of ambrisentan.
01/2007	Sitaxsentan: a selective endothelin-A receptor antagonist, for the treatment of pulmonary arterial hypertension.
12/2006	Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension.
05/2006	Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.
04/2006	Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension.
03/2006	Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial.
01/2006	Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension.
12/2005	Bone morphogenetic protein receptor 2 mutations in adults and children with idiopathic pulmonary arterial hypertension: association with thyroid disease.
11/2005	Sildenafil citrate therapy for pulmonary arterial hypertension.
11/2005	Sitaxsentan: a novel endothelin-A receptor antagonist for pulmonary arterial hypertension.
10/2005	von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension.
08/2005	Effects of long-term bosentan in children with pulmonary arterial hypertension.
11/2004	Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension.
10/2004	Sustained symptomatic, functional, and hemodynamic benefit with the selective endothelin-A receptor antagonist, sitaxsentan, in patients with pulmonary arterial hypertension: a 1-year follow-up study.
08/2004	Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.
06/2004	Endothelin receptor antagonists in pulmonary arterial hypertension.
02/2004	Sitaxsentan therapy for pulmonary arterial hypertension.
06/2003	Beraprost therapy for pulmonary arterial hypertension.
04/2003	Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension.
11/2002	Treprostinil therapy for pulmonary artery hypertension.
06/2002	Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study.
03/2002	Bosentan therapy for pulmonary arterial hypertension.
03/2002	Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.
02/2002	Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension.

Articles by Research Topic

Disease

30	Hypertension (High Blood Pressure) 10/2008 - 02/2002
5	Pulmonary Hypertension (Ayerza Syndrome) 12/2005 - 05/2002
3	Connective Tissue Diseases (Connective Tissue Disease) 12/2007 - 08/2004
1	Infection 04/2008
1	Thyroid Diseases (Thyroid Disease) 12/2005

Drug/Important Bio-Agent (IBA)

10	sitaxsentanIBA 10/2008 - 06/2002
7	Endothelin A ReceptorIBA 11/2007 - 06/2002
6	treprostinil FDA Link 03/2006 - 03/2002
5	bosentan (Tracleer)FDA Link 01/2007 - 03/2002
5	Epoprostenol (Prostacyclin)FDA LinkGeneric 12/2005 - 03/2002
3	sildenafil (Viagra)FDA Link 12/2007 - 08/2005
2	Iloprost (Ventavis)FDA Link 01/2008 - 12/2006
2	Serotonin (5 Hydroxytryptamine)IBA 01/2008 - 01/2006
2	beraprostIBA 03/2004 - 06/2003
1	ProstaglandinsIBA 04/2008
1	ambrisentan FDA Link 01/2007
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 04/2006
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 12/2005
1	von Willebrand FactorIBA 10/2005
1	Endothelin Receptors (Endothelin Receptor)IBA 06/2004
1	Thromboxane-A SynthaseIBA 05/2002
1	terbogrelIBA 05/2002

Therapy/Procedure

1	Cardiopulmonary Resuscitation (CPR) 02/2002